Form 8-K - Current report:
SEC Accession No. 0001564590-19-030069
Filing Date
2019-08-07
Accepted
2019-08-07 16:10:45
Documents
3
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arav-8k_20190807.htm 8-K 32568
2 EX-99.1 arav-ex991_77.htm EX-99.1 170590
3 GRAPHIC giqf1fifzina000001.jpg GRAPHIC 6135
  Complete submission text file 0001564590-19-030069.txt   212996
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

EIN.: 264106690 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 191005557
SIC: 2834 Pharmaceutical Preparations